Search

Your search keyword '"PF-04457845"' showing total 7 results

Search Constraints

Start Over You searched for: Descriptor "PF-04457845" Remove constraint Descriptor: "PF-04457845" Language english Remove constraint Language: english
7 results on '"PF-04457845"'

Search Results

1. Inhibition of FAAH suppresses RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss partially through repressing the IL17 pathway.

2. Inhibition of FAAH suppresses RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss partially through repressing the IL17 pathway.

3. An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee

4. Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects.

5. Different Routes to Inhibit Fatty Acid Amide Hydrolase: Do All Roads Lead to the Same Place?

6. Different Routes to Inhibit Fatty Acid Amide Hydrolase: Do All Roads Lead to the Same Place?

7. Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).

Catalog

Books, media, physical & digital resources